These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 303684)

  • 21. Reaginic antibody formation in the mouse. X. Possible role of suppressor T cells in transient IgE antibody responses.
    Tamura SI; Ishizaka K
    J Immunol; 1978 Mar; 120(3):837-43. PubMed ID: 305447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective suppression of host T cell and macrophage activities during 7,12-dimethylbenz[a]anthracene-induced carcinogenesis.
    Yamashita U; Hamaoka T
    Gan; 1982 Oct; 73(5):773-82. PubMed ID: 6219909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerance induction in B lymphocytes but thymus-dependent antigens. T cells may abrogate B-cell tolerance induction by prevent an antibody response.
    Schrader JW
    J Exp Med; 1975 May; 141(5):974-89. PubMed ID: 47898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of IgE antibody production in SJL mice. IV. Interaction of primed and unprimed T cells.
    Itaya T; Ovary Z
    J Exp Med; 1979 Sep; 150(3):507-16. PubMed ID: 314487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen structural requirements for immunoglobulin isotype switching in mice.
    Chen P; Nitecki DE; Lewis GK; Goodman JW
    J Exp Med; 1980 Dec; 152(6):1670-83. PubMed ID: 6161201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hapten-specific IgE antibody responses in mice. II. Cooperative interactions between adoptively transferred T and B lymphocytes in the development of IgE response.
    Hamaoka T; Katz DH; Benacerraf B
    J Exp Med; 1973 Sep; 138(3):538-56. PubMed ID: 4125546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships.
    Kontiainen S; Feldmann M
    J Exp Med; 1978 Jan; 147(1):110-22. PubMed ID: 415106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific suppression of anti-influenza antibody production in man. Possible role of a membrane-antigen complex.
    McCaughan GW; Brown MH; Basten A
    Eur J Immunol; 1985 Mar; 15(3):282-90. PubMed ID: 3156747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes.
    Abbas AK; Ratnofsky SE; Burakoff SJ
    J Exp Med; 1980 Aug; 152(2):306-23. PubMed ID: 6156985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-Ficoll. II. Hapten-reversible inhibition of anti-TNP plaque-forming cells by immune serum as an assay for auto-anti-idiotypic antibody.
    Goidl EA; Schrater AF; Siskind GW; Thorbecke GJ
    J Exp Med; 1979 Jul; 150(1):154-65. PubMed ID: 312904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens.
    Pierce CW; Kapp JA; Solliday SM; Dorf ME; Benacerraf B
    J Exp Med; 1974 Oct; 140(4):921-38. PubMed ID: 4610076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants.
    Pierres M; Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1978 Mar; 147(3):656-66. PubMed ID: 75939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VII. Idiotype-specific suppression of plaque-forming cell responses.
    Sherr DH; Ju ST; Weinberger JZ; Benacerraf B; Dorf ME
    J Exp Med; 1981 Mar; 153(3):640-52. PubMed ID: 7019373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular interactions in immune regulation. Hapten-specific suppression by non-T cells and T cell mediated reversal of suppression.
    DeKruyff RH; Simonson BG; Siskind GW
    J Exp Med; 1981 Oct; 154(4):1188-200. PubMed ID: 6169780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells.
    Schrater AF; Goidl EA; Thorbecke GJ; Siskind GW
    J Exp Med; 1979 Jul; 150(1):138-53. PubMed ID: 312903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hapten-specific hemolytic plaque assays usually fail to detect most of the diversity in the anti-hapten response.
    Merchant B; Inman JK
    J Exp Med; 1977 Feb; 145(2):372-89. PubMed ID: 64583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. I. Detection and characterization of hapten-reactive suppressor T-cell activity in mice immunized with hapten-isologous protein conjugate.
    Yamamoto H; Hamaoka T; Yoshizawa M; Kuroki M; Kitagawa M
    J Exp Med; 1977 Jul; 146(1):74-90. PubMed ID: 68994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of reaginic antibody production in mice. I. Suppression by antigen of IgE antibody production in vitro.
    Danneman PJ; Michael JG
    J Exp Med; 1977 Dec; 146(6):1534-48. PubMed ID: 562920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responses.
    Sherr DH; Minami M; Okuda K; Dorf ME
    J Exp Med; 1983 Feb; 157(2):515-29. PubMed ID: 6185612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.